Argent BioPharma Limited carries a market capitalization of 4.18M, placing it among publicly traded companies globally.
| Market Cap | 4.18M |
| Enterprise Value | N/A |
Argent BioPharma Limited's stock has declined approximately -70.73171% over the past 52 weeks. The 50-day moving average sits at 12.67, while the 200-day moving average is 17.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | -70.73171% |
| 50-Day Moving Average | 12.67 |
| 200-Day Moving Average | 17.67 |
| Average Volume (20 Days) | N/A |
Argent BioPharma Limited's most recent stock split took place on November 2, 2023 with a 1000:1 split ratio.
| Last Split Date | 11/2/2023 |
| Split Ratio | 1000:1 |